Cambridge, United Kingdom

Gillian McGregor Lamont

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Gillian McGregor Lamont: Innovator in Cancer Treatment

Introduction

Gillian McGregor Lamont is a distinguished inventor based in Cambridge, GB, renowned for her significant contributions to the field of cancer treatment. With a portfolio of three patents, she is at the forefront of innovative research aimed at combatting this formidable disease.

Latest Patents

Her latest invention pertains to Triazolopyrimidine compounds and their applications in treating cancer. This innovative work involves compounds of Formula (I), demonstrating potential in therapeutic uses, which could lead to advancements in the approach to cancer treatment.

Career Highlights

Gillian's professional journey includes pivotal roles at notable pharmaceutical companies such as Dizal Pharmaceutical Co., Ltd. and AstraZeneca AB. Her experience within these organizations has equipped her with a wealth of knowledge and expertise, allowing her to make impactful advancements in drug development.

Collaborations

Throughout her career, Gillian has collaborated with several esteemed colleagues, including Jason Grant Kettle and Frederick Woolf Goldberg. These collaborations have fostered a creative and productive environment for innovation in medical research.

Conclusion

Gillian McGregor Lamont's contributions to the field of cancer treatment through her patented inventions exemplify her dedication to advancing healthcare. Her ongoing work continues to inspire future developments in the treatment of cancer, solidifying her position as a key figure in the realm of pharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…